Pharmcube

About Pharmcube

Founded in 2015, Pharmcube operates as a big data and artificial intelligence platform tailored for the pharmaceutical industry. The company, officially Beijing HuaBinLiCheng Technology Co., Ltd., is headquartered in Shanghai, China, and was established by Jean Cheng and Liyun Zhou. Pharmcube aims to address the high costs and lengthy timelines associated with drug development by providing data-driven insights that help clients make more informed decisions.

The firm's core business revolves around a comprehensive suite of data products and consulting services that span the entire lifecycle of pharmaceutical products. Its client base includes pharmaceutical companies, investment institutions, and healthcare researchers who require in-depth data and market analysis. Revenue is generated through subscriptions to its various databases, customized consulting projects, and media services. The company has established partnerships with nearly a thousand leading pharmaceutical companies and investment institutions.

Pharmcube's platform integrates and standardizes vast amounts of global pharmaceutical data related to drug research and development, clinical trials, patents, market competition, regulatory approvals, and sales. This is achieved through the use of AI technologies like natural language processing and machine learning. The product matrix includes offerings such as NextBiopharm, a global new drug database; MedAlpha, a database for healthcare investment and financing in China; TrialCube, a global clinical trial database; and PharmaBI, a market sales database. Beyond its data products, the company offers consulting on competitive landscapes, clinical evaluation strategies, market potential assessment, and pipeline planning. It also provides media services, including medical visualizations and webinars, to an audience of over 800,000 industry professionals.